Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit)

v3.23.2
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2021   114,452,000    
Balance at beginning of period at Dec. 31, 2021 $ 179,620 $ 11 $ 650,518 $ (470,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 10,862   10,862  
Issuance of common stock upon exercise of stock options (in shares)   404,000    
Issuance of common stock upon exercise of stock options 17   17  
Issuance of common stock upon vesting of restricted stock awards (in shares)   129,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   4,816,000    
Issuance of common stock upon vesting of restricted stock units 1 $ 1    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   1,874,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (3,616)   (3,616)  
Net loss (19,992)     (19,992)
Balance at end of period (in shares) at Mar. 31, 2022   117,927,000    
Balance at end of period at Mar. 31, 2022 166,892 $ 12 657,781 (490,901)
Balance at beginning of period (in shares) at Dec. 31, 2021   114,452,000    
Balance at beginning of period at Dec. 31, 2021 179,620 $ 11 650,518 (470,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (46,274)      
Balance at end of period (in shares) at Jun. 30, 2022   118,453,000    
Balance at end of period at Jun. 30, 2022 143,539 $ 12 660,710 (517,183)
Balance at beginning of period (in shares) at Mar. 31, 2022   117,927,000    
Balance at beginning of period at Mar. 31, 2022 166,892 $ 12 657,781 (490,901)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 3,365   3,365  
Issuance of common stock upon exercise of stock options (in shares)   180,000    
Issuance of common stock upon exercise of stock options 8   8  
Issuance of common stock upon vesting of restricted stock awards (in shares)   27,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   520,000    
Issuance of common stock upon vesting of restricted stock units 0 $ 0    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   201,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (444)   (444)  
Net loss (26,282)     (26,282)
Balance at end of period (in shares) at Jun. 30, 2022   118,453,000    
Balance at end of period at Jun. 30, 2022 $ 143,539 $ 12 660,710 (517,183)
Balance at beginning of period (in shares) at Dec. 31, 2022 119,508,000 119,508,000    
Balance at beginning of period at Dec. 31, 2022 $ 121,874 $ 12 666,973 (545,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 3,214   3,214  
Issuance of common stock upon exercise of stock options (in shares)   129,000    
Issuance of common stock upon exercise of stock options 3   3  
Issuance of common stock upon vesting of restricted stock awards (in shares)   11,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   787,000    
Issuance of common stock upon vesting of restricted stock units 0 $ 0    
Issuance of common stock (in shares)   16,404,000    
Issuance of common stock 11,129 $ 2 11,127  
Net loss (17,315)     (17,315)
Balance at end of period (in shares) at Mar. 31, 2023   136,839,000    
Balance at end of period at Mar. 31, 2023 $ 118,905 $ 14 681,317 (562,426)
Balance at beginning of period (in shares) at Dec. 31, 2022 119,508,000 119,508,000    
Balance at beginning of period at Dec. 31, 2022 $ 121,874 $ 12 666,973 (545,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (50,746)      
Balance at end of period (in shares) at Jun. 30, 2023 138,409,000 138,409,000    
Balance at end of period at Jun. 30, 2023 $ 88,545 $ 14 684,388 (595,857)
Balance at beginning of period (in shares) at Mar. 31, 2023   136,839,000    
Balance at beginning of period at Mar. 31, 2023 118,905 $ 14 681,317 (562,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 2,488   2,488  
Issuance of common stock upon exercise of stock options (in shares)   95,000    
Issuance of common stock upon exercise of stock options 2   2  
Issuance of common stock upon vesting of restricted stock awards (in shares)   8,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   668,000    
Issuance of common stock (in shares)   1,039,000    
Issuance of common stock 995   995  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   240,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (414)   (414)  
Net loss $ (33,431)     (33,431)
Balance at end of period (in shares) at Jun. 30, 2023 138,409,000 138,409,000    
Balance at end of period at Jun. 30, 2023 $ 88,545 $ 14 $ 684,388 $ (595,857)